Inspire Medical Systems Stock Today
| INSP Stock | USD 185.61 1.54 0.82% |
PerformanceInsignificant
| Odds Of DistressVery Small
|
Inspire Medical is selling at 185.61 as of the 16th of February 2025; that is 0.82 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 183.64. Inspire Medical has a very small chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. The performance scores are derived for the period starting the 18th of November 2024 and ending today, the 16th of February 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 3rd of May 2018 | Category Healthcare | Classification Health Care |
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea in the United States and internationally. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. The company has 29.67 M outstanding shares of which 2.52 M shares are currently shorted by private and institutional investors with about 4.21 trading days to cover. More on Inspire Medical Systems
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Inspire Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO | Timothy Herbert | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Inspire Semiconductor Holdings Inc. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Technology, Health Care Equipment & Services, Health Care, NYSE Composite, SP Small-Cap 600, Health Care, Health Care Technology, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsInspire Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Inspire Medical's financial leverage. It provides some insight into what part of Inspire Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inspire Medical Systems (INSP) is traded on New York Stock Exchange in USA. It is located in 5500 Wayzata Blvd., Golden Valley, MN, United States, 55416 and employs 1,246 people. Inspire Medical is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.51 B. Inspire Medical Systems conducts business under Health Care Technology sector and is part of Health Care industry. The entity has 29.67 M outstanding shares of which 2.52 M shares are currently shorted by private and institutional investors with about 4.21 trading days to cover.
Inspire Medical Systems currently holds about 196.32 M in cash with 130.25 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.1.
Check Inspire Medical Probability Of Bankruptcy
Ownership AllocationThe majority of Inspire Medical Systems outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Inspire Medical to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Inspire Medical Systems. Please pay attention to any change in the institutional holdings of Inspire Medical Systems as this could imply that something significant has changed or is about to change at the company.
Check Inspire Ownership Details
Inspire Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Bank Of New York Mellon Corp | 2024-12-31 | 580.9 K | |
| Artisan Partners Limited Partnership | 2024-09-30 | 545.9 K | |
| Hhg Plc | 2024-09-30 | 502.6 K | |
| Geode Capital Management, Llc | 2024-09-30 | 483.7 K | |
| Champlain Investment Partners, Llc | 2024-09-30 | 464.6 K | |
| Aqr Capital Management Llc | 2024-09-30 | 446.4 K | |
| Timessquare Capital Management, Llc | 2024-12-31 | 433.8 K | |
| Frontier Capital Management Co Inc | 2024-09-30 | 395 K | |
| Ubs Asset Mgmt Americas Inc | 2024-09-30 | 365.2 K | |
| Blackrock Inc | 2024-09-30 | 4.1 M | |
| Vanguard Group Inc | 2024-09-30 | 3.2 M |
Inspire Medical Historical Income Statement
Inspire Stock Against Markets
Inspire Medical Corporate Directors
| Georgia GarinoisMelenikiotou | Independent Director | Profile | |
| Megan CPA | Director Reporting | Profile | |
| Shawn McCormick | Independent Director | Profile | |
| Jerry Griffin | Independent Director | Profile |
Additional Tools for Inspire Stock Analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.